These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6238401)

  • 1. Effect of bestatin on in vitro responses of murine lymphocytes to T-cell stimuli.
    Dunlap BE; Dunlap SA; Rich DH
    Scand J Immunol; 1984 Sep; 20(3):237-45. PubMed ID: 6238401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenic effect of bestatin on lymphocytes.
    Ishizuka M; Sato J; Sugiyama Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Jun; 33(6):653-62. PubMed ID: 7419476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of T cells to mutant major histocompatibility complex class I antigen. II. Role of stimulator-type accessory cells with reference to interleukin 1 production.
    Watanabe H; Saitoh T; Fujiwara M
    Scand J Immunol; 1989 Mar; 29(3):343-51. PubMed ID: 2524093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of bestatin on the growth of human lymphocytes.
    Ino K; Isobe K; Goto S; Nakashima I; Tomoda Y
    Immunopharmacology; 1992; 23(3):163-71. PubMed ID: 1500283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of age-associated immune decline and mortality by early repeated administration of bestatin to C57BL/6 mice.
    Bruley-Rosset M; Payelle B; Rappaport H
    J Biol Response Mod; 1986 Apr; 5(2):176-90. PubMed ID: 3488372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bestatin, an inhibitor of aminopeptidases, on T and B lymphocyte subsets in mice.
    Lis M; Szczypka M; Suszko A; Obmińska-Mrukowicz B
    Pol J Vet Sci; 2011; 14(3):393-403. PubMed ID: 21957733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with Bestatin.
    Noma T; Klein B; Cupissol D; Yata J; Serrou B
    Int J Immunopharmacol; 1984; 6(2):87-92. PubMed ID: 6429060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of immunosuppressive treatment on the in vitro activity of mouse lymphoid cells after stimulation by PHA and allogeneic cells.
    Snippe H; Bruijnzeel PL; Willers JM
    Int Arch Allergy Appl Immunol; 1973; 45(5):731-43. PubMed ID: 4270693
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunomodulatory and therapeutic properties of bestatin in mice.
    Talmadge JE; Lenz BF; Pennington R; Long C; Phillips H; Schneider M; Tribble H
    Cancer Res; 1986 Sep; 46(9):4505-10. PubMed ID: 2942238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bestatin, a new immunomodulator, augments the release of mitogenic factors from PHA-stimulated human lymphocytes.
    Blomgren H
    Biomedicine; 1981 Dec; 34(4):188-92. PubMed ID: 6979352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the effect of indomethacin and preincubation on the lymphoproliferative response to concanavalin A of spleen cells from low responder C57BL/6 and high responder BALB/c mice.
    Malavé I; Araujo Z
    Int J Immunopharmacol; 1986; 8(2):137-46. PubMed ID: 3710662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bestatin on phagocytic cells in cyclophosphamide-treated mice.
    Lis M; Obmińska-Mrukowicz B
    Pharmacol Rep; 2011; 63(6):1481-90. PubMed ID: 22358096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous interleukin-2 abrogates differences in the proliferative responses to T cell mitogens among inbred strains of mice.
    Lipoldová M; Zajícová A; Stĕdra J; Holán V
    Cell Immunol; 1992 Jun; 142(1):177-85. PubMed ID: 1586954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of interleukins in synergistic effect of Bu-WSA on concanavalin A-induced DNA synthesis in mouse splenic lymphocytes.
    Nitta T; Konno-Ejiri H; Nemoto K; Okumura S; Ozawa A; Nakano M
    Scand J Immunol; 1986 Sep; 24(3):297-305. PubMed ID: 3489286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lymphocyte mitogenesis in mice infected with Newcastle disease virus: viral interference with the interleukin system.
    Colonna Romano G; Dieli F; Abrignani S; Salerno A; Colizzi V
    Immunology; 1986 Mar; 57(3):373-8. PubMed ID: 2937717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discodermolide--a new, marine-derived immunosuppressive compound. I. In vitro studies.
    Longley RE; Caddigan D; Harmody D; Gunasekera M; Gunasekera SP
    Transplantation; 1991 Oct; 52(4):650-6. PubMed ID: 1833864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.
    Altman A; Theofilopoulos AN; Weiner R; Katz DH; Dixon FJ
    J Exp Med; 1981 Sep; 154(3):791-808. PubMed ID: 6456321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.